Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.
Clicks: 248
ID: 106733
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
76.9
/100
240 views
196 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Infectious vaginitis due to bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and accounts for a significant proportion of all gynecologic visits in the United States. A prospective multicenter clinical study was conducted to validate the performance of two new diagnostic transcription-mediated amplification nucleic acid amplification tests (NAATs) for diagnosis of BV, VVC, and trichomoniasis. Patient- and clinician-collected vaginal-swab samples obtained from women with symptoms of vaginitis were tested with the Aptima BV and Aptima vaginitis (CV/TV) assays. The results were compared to Nugent (plus Amsel for intermediate Nugent) scores for BV, cultures and DNA sequencing for VVC, and a composite of NAAT and culture for The prevalences of infection were similar for clinician- and patient-collected samples: 49% for BV, 29% for VVC due to the species group, 4% for VVC due to , and 10% for Sensitivity and specificity estimates for the investigational tests in clinician-collected samples were 95.0% and 89.6%, respectively, for BV; 91.7% and 94.9% for the species group; 84.7% and 99.1% for ; and 96.5% and 95.1% for Sensitivities and specificities were similar in patient-collected samples. In a secondary analysis, clinicians' diagnoses, in-clinic assessments, and investigational-assay results were compared to gold standard reference methods. Overall, the investigational assays had higher sensitivity and specificity than clinicians' diagnoses and in-clinic assessments, indicating that the investigational assays were more predictive of infection than traditional diagnostic methods. These results provide clinical-efficacy evidence for two diagnostic NAATs that can detect the main causes of vaginitis.
| Reference Key |
schwebke2020clinicaljournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Schwebke, Jane R;Taylor, Stephanie N;Ackerman, Ronald;Schlaberg, Robert;Quigley, Neil B;Gaydos, Charlotte A;Chavoustie, Steven E;Nyirjesy, Paul;Remillard, Carmelle V;Estes, Philip;McKinney, Byron;Getman, Damon K;Clark, Craig; |
| Journal | Journal of clinical microbiology |
| Year | 2020 |
| DOI |
e01643-19
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.